Soni Medicare [SML] vs Shalby [SHALBY] Detailed Comparison
Soni Medicare
BSE
Loading...
Shalby
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Soni Medicare wins in 9 metrics, Shalby wins in 8 metrics, with 0 ties. Soni Medicare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Soni Medicare | Shalby | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 1,219.53 | N/A |
| Price-to-Book Ratio | 11.20 | 2.04 | Shalby |
| Debt-to-Equity Ratio | 810.21 | 9.69 | Shalby |
| PEG Ratio | N/A | 22.06 | N/A |
| EV/EBITDA | 18.21 | 13.66 | Shalby |
| Profit Margin (TTM) | -0.60% | 0.57% | Shalby |
| Operating Margin (TTM) | 7.28% | 1.74% | Soni Medicare |
| EBITDA Margin (TTM) | 7.28% | 1.74% | Soni Medicare |
| Return on Equity | -12.79% | 0.19% | Shalby |
| Return on Assets (TTM) | 2.28% | 2.52% | Shalby |
| Free Cash Flow (TTM) | $8.76M | $-757.89M | Soni Medicare |
| Dividend Yield | N/A | 0.65% | N/A |
| 1-Year Return | 105.82% | -28.14% | Soni Medicare |
| Price-to-Sales Ratio (TTM) | 0.79 | 2.05 | Soni Medicare |
| Enterprise Value | $230.56M | $18.11B | Shalby |
| EV/Revenue Ratio | 0.74 | 1.67 | Soni Medicare |
| Gross Profit Margin (TTM) | 53.06% | 37.50% | Soni Medicare |
| Revenue per Share (TTM) | $124 | $112 | Soni Medicare |
| Earnings per Share (Diluted) | $-0.44 | $0.17 | Shalby |
| Beta (Stock Volatility) | -0.40 | 0.45 | Soni Medicare |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Soni Medicare vs Shalby Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Soni Medicare | 1.99% | 2.43% | 20.16% | -8.14% | 55.00% | 71.97% |
| Shalby | 1.31% | 6.05% | 13.22% | 9.97% | -1.48% | -10.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Soni Medicare | 105.82% | 153.81% | 56.35% | 253.53% | 253.53% | 253.53% |
| Shalby | -28.14% | 75.17% | 175.02% | -16.04% | -16.04% | -16.04% |
Performance & Financial Health Analysis: Soni Medicare vs Shalby
| Metric | SML | SHALBY |
|---|---|---|
| Market Information | ||
| Market Cap | ₹246.30M | ₹22.24B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,877 | 494,942 |
| 90 Day Avg. Volume | 3,747 | 241,843 |
| Last Close | ₹58.90 | ₹207.55 |
| 52 Week Range | ₹24.99 - ₹85.44 | ₹177.25 - ₹297.90 |
| % from 52W High | -31.06% | -30.33% |
| All-Time High | ₹85.44 (May 05, 2025) | ₹339.50 (Jan 22, 2024) |
| % from All-Time High | -31.06% | -38.87% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.09% |
| Quarterly Earnings Growth | 0.00% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.01% |
| Operating Margin (TTM) | 0.07% | 0.02% |
| Return on Equity (TTM) | -0.13% | 0.00% |
| Debt to Equity (MRQ) | 810.21 | 9.69 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹5.16 | ₹101.79 |
| Cash per Share (MRQ) | ₹7.98 | ₹32.80 |
| Operating Cash Flow (TTM) | ₹15.36M | ₹-43,430,000 |
| Levered Free Cash Flow (TTM) | ₹-157,634 | ₹-887,275,008 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.65% |
| Last 12-Month Dividend | N/A | ₹1.20 |
Valuation & Enterprise Metrics Analysis: Soni Medicare vs Shalby
| Metric | SML | SHALBY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 1,219.53 |
| Forward P/E | N/A | 22.06 |
| PEG Ratio | N/A | 22.06 |
| Price to Sales (TTM) | 0.79 | 2.05 |
| Price to Book (MRQ) | 11.20 | 2.04 |
| Market Capitalization | ||
| Market Capitalization | ₹246.30M | ₹22.24B |
| Enterprise Value | ₹230.56M | ₹18.11B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.74 | 1.67 |
| Enterprise to EBITDA | 18.21 | 13.66 |
| Risk & Other Metrics | ||
| Beta | -0.40 | 0.45 |
| Book Value per Share (MRQ) | ₹5.16 | ₹101.79 |
Financial Statements Comparison: Soni Medicare vs Shalby
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SML | SHALBY |
|---|---|---|
| Revenue/Sales | ₹68.68M | ₹2.65B |
| Cost of Goods Sold | ₹32.24M | ₹1.66B |
| Gross Profit | ₹36.45M | ₹993.23M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹5.47M | ₹46.11M |
| EBITDA | ₹6.96M | ₹261.61M |
| Pre-Tax Income | ₹2.61M | ₹-7.38M |
| Income Tax | ₹-859,000 | ₹114.50M |
| Net Income (Profit) | ₹3.47M | ₹-121.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SML | SHALBY |
|---|---|---|
| Cash & Equivalents | ₹20.10M | ₹347.85M |
| Total Current Assets | ₹137.75M | ₹6.58B |
| Total Current Liabilities | ₹103.85M | ₹4.55B |
| Long-Term Debt | ₹94.12M | ₹1.75B |
| Total Shareholders Equity | ₹13.08M | ₹9.95B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹60.31M | ₹8.88B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SML | SHALBY |
|---|---|---|
| Operating Cash Flow | N/A | ₹433.19M |
| Capital Expenditures | N/A | ₹-563.59M |
| Free Cash Flow | N/A | ₹-66.61M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SML | SHALBY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,877 | 494,942 |
| Average Daily Volume (90 Day) | 3,747 | 241,843 |
| Shares Outstanding | 4.26M | 107.27M |
| Float Shares | 415,445 | 24.09M |
| % Held by Insiders | 0.83% | 0.67% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Soni Medicare vs Shalby
| Metric | SML | SHALBY |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹1.20 |
| Last 12-Month Dividend Yield | N/A | 0.65% |
| 3-Year Avg Annual Dividend | N/A | ₹1.08 |
| 3-Year Avg Dividend Yield | N/A | 0.55% |
| 3-Year Total Dividends | N/A | ₹3.23 |
| Ex-Dividend Date | N/A | Sep 19, 2024 |